Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists.

Expert Opinion on Emerging Drugs
Raj A ShahKris V Kowdley

Abstract

The discovery of the farnesoid X receptor and its role in bile and lipid homeostasis has led to the investigation of FXR agonists as a therapy in cholestatic disorders and in NAFLD. With increasing prevalence of obesity and metabolic syndrome, NAFLD has grown to become the most prevalent chronic liver disease, present in a quarter of the worldwide population. FXR agonists represent a promising avenue for this burgeoning disease with few options for pharmacologic therapy. A brief overview of the epidemiology of NAFLD/NASH and a review of current evidence on available treatments is provided. For FXR agonists, a review is performed of mechanisms of action, efficacy, and adverse effects. Finally, hurdles to widespread adoption of this drug class in treatment of NASH are described. Prospective clinical trials were reviewed on the US National Library of Medicine database at clinicaltrials.gov, along with a literature search of meta-analyses, reviews, and original research. FXR agonists show promise for treating NASH with positive effects on several surrogate markers of disease including liver fibrosis on biopsy, fat reduction on MRI, and decrease in liver enzymes. However, their long-term tolerability, safety, and efficacy on liver-r...Continue Reading

References

Aug 9, 2002·Journal of Medicinal Chemistry·Roberto PellicciariTimothy M Willson
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Jun 9, 2005·Gastroenterology·Vlad RatziuUNKNOWN LIDO Study Group
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtStergios Kechagias
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yan-Dong WangWendong Huang
Dec 10, 2009·The Journal of Biological Chemistry·Yanqiao ZhangPeter A Edwards
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
Nov 6, 2010·BMJ : British Medical Journal·Markus SchürksTobias Kurth
Jan 18, 2011·Current Aging Science·Erin L AbnerRichard J Kryscio
Mar 4, 2011·The American Journal of Clinical Nutrition·Jeffrey D BrowningShawn C Burgess
Oct 13, 2011·JAMA : the Journal of the American Medical Association·Eric A KleinLaurence H Baker
Mar 26, 2013·The Journal of Clinical Investigation·Farzad AlemiCarlos U Corvera
Apr 1, 2014·Cell·Ronald M Evans, David J Mangelsdorf
Aug 26, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Sahil MittalJessica A Davila
Apr 14, 2015·Gastroenterology·Eduardo Vilar-GomezManuel Romero-Gomez
Jun 6, 2015·Digestive Diseases·Steven A Kliewer, David J Mangelsdorf
Aug 15, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiSharon Hunt
Oct 18, 2015·Biochemical and Biophysical Research Communications·Liangpeng LiYu Jiang
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Apr 1, 2016·BMJ : British Medical Journal·Marco TuccoriLaurent Azoulay
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
May 9, 2016·The Lancet. Diabetes & Endocrinology·Edward W GreggMohammed K Ali
May 24, 2016·Journal of Hepatology·Giovanni TargherCorrado Barbui
Oct 23, 2016·Journal of Hepatology·Ryuki HashidaTakuji Torimura
Jun 18, 2017·Nature Reviews. Endocrinology·Ruth C R Meex, Matthew J Watt
Jul 18, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Naga ChalasaniArun J Sanyal
Jul 27, 2017·Digestive Diseases and Sciences·George CholankerilAijaz Ahmed
Dec 17, 2017·Journal of Gastroenterology·Yoshio Sumida, Masashi Yoneda

❮ Previous
Next ❯

Citations

Apr 16, 2021·Expert Opinion on Emerging Drugs·Jonathan Andrew FallowfieldAndrew Robertson
Sep 18, 2021·ACS Medicinal Chemistry Letters·Joseph CarpenterDean A Wacker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.